Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn

Company News Summary

Mesoblast Presents Corporate Updates at Global Healthcare Conferences

25 Sep 2017  |  11:09:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Mesoblast Corporate Updates at Healthcare Conferences

Mesoblast announced that the Company will present corporate updates at the annual Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann Healthcare Conference, both being held in New York City, New York. The Company presentations will focus on the Phase 3 clinical trials of its product candidates in acute graft versus host disease (aGVHD), chronic low back pain due to disc degeneration (CLBP), and chronic heart failure (CHF), and on potential regulatory strategies to achieve accelerated approval pathways for these product candidates based on the serious and life-threatening nature of the diseases and the cumulative clinical results obtained to date using the Company's proprietary mesenchymal lineage cell technology platforms.

Please click here for full details

See more ASX300 News Announcements